Roche has reached an agreement to acquire Flatiron Health, a NYC-based oncology EHR startup focused on accelerating cancer research and improving patient care for $1.9B. Under terms of the acquisition, Flatiron Health will continue its current business model, network of partnerships and overall objectives. The integrity of segregated patient protected health information will be preserved, as will dedicated sales and marketing, provider-facing and life science business activities. In addition, the integrity of segregated patient protected health information will be preserved, as will dedicated sales and marketing, provider-facing and life science business activities.
The acquisition will bring together two companies committed to improving the lives of cancer patients through the evolving field of healthcare data and analytics.
With its large network of community oncology practices and academic medical centers across the US, Flatiron Health has created a technology platform designed to learn from the experience of every patient. Together, the companies will leverage their combined expertise to advance the use of real-world evidence to set new industry standards for oncology research and development. Currently, Flatiron partners with over 265 community cancer clinics, six major academic research centers and 14 out of the top 15 therapeutic oncology companies.
“This is an important step in our personalized healthcare strategy for Roche, as we believe that regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments. As a leading technology company in oncology, Flatiron Health is best positioned to provide the technology and data analytics infrastructure needed not only for Roche, but for oncology research and development efforts across the entire industry. A key principle of this is to preserve Flatiron’s autonomy and their ability to continue providing their services to all existing and future partners,” said Daniel O’Day, CEO Roche Pharmaceuticals in a statement.